Familial longevity

Familial longevity has been studied in 3 papers since 2017: 3 observational studies in people. The newest paper, Jan 14, 2023: “Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study”.

Exposure

3 papers study it6 findingsUpdated

See all 3 papers on familial longevity

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“offspring were 46% less likely to have baseline cognitive impairment (adjusted odds ratio 0.54, 95% CI 0.35-0.82)”
Reduced Prevalence and Incidence of Cognitive Impairment Among Centenarian OffspringThe journals of gerontology. Series A, Biological sciences and medical sciences2018doi:10.1093/gerona/gly141

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Instituto de Salud Carlos III and 3 more
  • Humans3

What did studies of familial longevity find?

4

Studies of familial longevity measured 4 outcomes, among them muscle mass, IL-6 and robust status.

Muscle mass

no changein humans1

1 study
  1. Familial longevity was not clearly linked with muscle mass in humans.

    “No significant differences in muscle mass were found.”

    Humans

    Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study

    International journal of environmental research and public health

IL-6

downin humans1

1 study
  1. Familial longevity is linked with lower IL-6 in humans.

    “and lower levels of IL-6 (p = 0.044) than controls.”

    Humans

    Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study

    International journal of environmental research and public health

More on IL-6

Robust status

upin humans1OR 3

1 study
  1. Familial longevity is linked with higher robust status in humans (adjusted OR 3.00 (95% CI 1.06-8.47)).

    “The robust adjusted OR for cases was 3.00 (95% CI = 1.06-8.47, p = 0.038).”

    Humans

    Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study

    International journal of environmental research and public health

Frailty

downin humans1

1 study
  1. Familial longevity is linked with lower frailty in humans (frail 9.1% vs. 21.6% in controls).

    “Cases had a higher percentage of robust patients (31.8% vs. 15.9%), lower percentages of frailty (9.1% vs. 21.6%)”

    Humans

    Effect of Familial Longevity on Frailty and Sarcopenia: A Case-Control Study

    International journal of environmental research and public health

What is familial longevity linked with?

2

Studies link familial longevity with 2 measures: incident cognitive impairment and cognitive impairment.

Incident cognitive impairment

downin humans1

1 study
  1. Familial longevity is linked with a lower risk of incident cognitive impairment in humans (adjusted for age, sex, education, stroke, and diabetes) (adjusted hazard ratio 0.73, 95% CI 0.53-0.99).

    “were 27% less likely to become cognitively impaired over a median follow-up of 7.8 years (adjusted hazard ratio 0.73, 95% CI 0.53-0.99)”

    Humansadjusted for age, sex, education, stroke, and diabetesmedian follow-up of 7.8 years

    Reduced Prevalence and Incidence of Cognitive Impairment Among Centenarian Offspring

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Incident cognitive impairment

Cognitive impairment

downin humans1

1 study
  1. Familial longevity is linked with a lower risk of cognitive impairment in humans (adjusted for age, sex, education, stroke, and diabetes) (adjusted odds ratio 0.54, 95% CI 0.35-0.82).

    “offspring were 46% less likely to have baseline cognitive impairment (adjusted odds ratio 0.54, 95% CI 0.35-0.82)”

    Humansadjusted for age, sex, education, stroke, and diabetes

    Reduced Prevalence and Incidence of Cognitive Impairment Among Centenarian Offspring

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Cognitive impairment

Latest